Midlife Glow
Advanced scientific inquiry into dermal thickness, extracellular matrix remodeling, collagen turnover, and microvascular perfusion during hormonal shifts in midlife.
Dermal Architecture & Tissue Matrix Formulations
DermalMatrix™
Direct investigation into estrogen-related dermal thinning, loss of skin elasticity, and collagen cross-link degradation. GHK-Cu stimulates type I/III procollagen, while BPC-157 supports microvascular capillary angiogenesis.
SomatroPulse™
Explores growth hormone pulsatile release, cellular turnover, visceral fat mobilization, and lean tissue retention during age-related somatopause.
RegenMatrix™
Synergistic actin upregulation and VEGF stimulation targeting tendon elasticity, menopausal ligament stiffness, and systemic soft tissue repair.
Understanding Dermal Collagen Decline in Midlife
During the perimenopausal transition and the subsequent postmenopausal years, systemic estrogen levels decline sharply. Dermatology research has established that skin loses approximately 30% of its dermal collagen within the first five years following menopause, followed by an annual loss of approximately 2.1% thereafter.
Key Cellular Mechanisms Under Investigation:
- GHK-Cu Copper Tripeptide: Pickart et al. demonstrated that GHK-Cu regulates over 4,000 human genes, shifting gene expression toward younger, regenerative profiles. It stimulates collagen I, collagen III, elastin, and decorin synthesis.
- Capillary Perfusion & VEGF: Age-related dermal pallor and thinning are tightly linked to diminished microvascular flow. BPC-157 stimulates vascular endothelial growth factor (VEGF) receptor activation to promote microcirculatory perfusion.
- Growth Hormone Somatopause: The age-related drop in nocturnal GH pulses impairs systemic cellular turnover. GHRH agonists (CJC-1295) and selective GH secretagogues (Ipamorelin) are studied for restorative physiological GH pulsatility without desensitization.
Questions About Dermal Research Compounds
DermalMatrix™, SomatroPulse™, and RegenMatrix™ are analytical chemical reagents intended exclusively for in vitro laboratory research and academic study. They are not licensed medicines, cosmetics, or topical therapeutic products, and must not be used on humans.
